Nutritional advice

Objectives:
What is the effect of aerobic exercise performed in the fasted versus fed states on fat and carbohydrate metabolism in adults?

Study design:
This review article included 27 studies with a total of 273 participants.

Results and conclusions:
The investigators found a significant increase in fat oxidation during aerobic exercise (duration ≤120 min) performed in the fasted state compared with fed state [WMD = -3.08 g, 95% CI = -5.38 to -0.79, I2 = 39.1%].

The investigators found the weighted mean difference of onesterified fatty acids (NEFA) concentrations was not significantly different between states [WMD = 0.00 mmol/L, 95 % CI = -0.07 to 0.08, I2 = 72.7 %].

The investigators found, however, the weighted mean differences of glucose [WMD = 0.78 mmol/L, 95% CI = 0.43 to 1.14, I2 = 90.8%] and insulin concentrations [WMD = 104.5 pmol/L, 95% CI = 70.8 to 138.2, I2 = 94.5%] were significantly higher for aerobic exercise (duration ≤120 min) performed in the fed state.

The investigators concluded that aerobic exercise (duration ≤120 min) performed in the fasted state induces higher fat oxidation than aerobic exercise performed in the fed state.

Original title:
Effects of aerobic exercise performed in fasted v. fed state on fat and carbohydrate metabolism in adults: a systematic review and meta-analysis by Vieira AF, Costa RR, […], Kruel LF.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/27609363

Additional information of El Mondo:
Find more studies/information on physical activity and energy right here.

Aerobic exercise is any exercise that raises the heart rate and increases respiration (breathing). Examples of aerobic exercise are:

• Cross-country skiing
• Cycling
• Dancing
• Fast walking
• Hiking
• Jogging or running
• Swimming
   

Objectives:
There is an ongoing debate on the involvement of systemic copper (Cu) dysfunctions in Alzheimer's disease (AD) and clinical studies comparing Cu levels in serum, plasma and cerebrospinal fluid (CSF) of AD patients with those of healthy controls have delivered non-univocal and often conflicting results. Therefore, this review article has been conducted.

Does blood level of copper increase in Alzheimer’s disease?

Study design:
This review article included 26 studies including a pooled total of 761 AD subjects and 664 controls for serum Cu studies, 205 AD subjects and 167 controls for plasma Cu and of 116 AD subjects and 129 controls for CSF Cu.

Results and conclusions:
The investigators found Alzheimer's disease patients have higher levels of serum copper than healthy controls. Plasma data did not allow conclusions, due to their high heterogeneity, but the meta-analysis of the combined serum and plasma studies confirmed higher copper levels in Alzheimer's disease patients. 

The investigators found the analysis of CSF data revealed no difference between Alzheimer's disease patients and controls.

The investigators concluded Alzheimer's disease patients have higher levels of serum and plasma copper than healthy controls.

Original title:
Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies by Bucossi S, Ventriglia M, […], Squitti R.

Link:
http://www.ncbi.nlm.nih.gov/pubmed/21187586

Additional information of El Mondo:
Find more information/studies on copper and dementia right here.

Objectives:
The association between elevated serum phosphorus concentration and cardiovascular or all-cause mortality yielded conflicting results. Therefore, this review article (meta-analysis) has been conducted.

Does an elevated serum phosphorus concentration increase cardiovascular and all-cause mortality in the general population?

Study design:
This review article included 6 prospective cohort studies involving 120,269 subjects.

Results and conclusions:
The investigators found when compared the highest with the reference concentration of serum phosphorus, a significant increased risk of 36% for cardiovascular mortality [pooled RR = 1.36, 95% CI = 1.07-1.72]. Significant because RR of 1 was not found in the 95% CI of 1.07 to 1.72. RR of 1 means no risk/association.

The investigators found when compared the highest with the reference concentration of serum phosphorus, a significant increased risk of 33% for all-cause mortality [pooled RR = 1.33, 95% CI = 1.15-1.58]. Significant means that there is an association with a 95% confidence.

The investigators found stratified analyses revealed that elevated serum phosphorus significantly increased all-cause mortality risk with 33% among men [RR 1.33, 95% CI = 1.11-1.60], but not in women [RR = 1.09, 95% CI = 0.89-1.33].

The investigators concluded elevated serum phosphorus concentration is independently associated with excessive risk of cardiovascular and all-cause mortality in the general population without chronic kidney disease. Serum phosphorus on all-cause mortality risk appears to be pronounced in men but exhibits no clear effect on women. However, gender difference of elevated serum phosphorus on mortality risk should be verified by more prospective cohort studies.

Original title:
Serum phosphorus, cardiovascular and all-cause mortality in the general population: A meta-analysis by Bai W, Li J and Liu J.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/27475981

Additional information of El Mondo:
Find more studies/information on elderly and phosphorus right here.

Objectives:
Reported associations between protein intake from different sources and type 2 diabetes (T2D) have been inconsistent.Therefore, this review article has been conducted.

Study design:
This review article included 11 prospective cohort studies with 505,624 participants and 37,918 type 2 diabetes cases (follow-up range: 5-24 years).

Results and conclusions:
The investigators found for the comparison of the highest with lowest categories of total protein intakes a significant higher risk of 9% for type 2 diabetes [RR = 1.09, 95% CI = 1.06 to 1.13]. Significant means that there is an association with a 95% confidence.

The investigators found for the comparison of the highest with lowest categories of animal protein intakes a significant higher risk of 19% for type 2 diabetes [RR = 1.19, 95% CI = 1.11 to 1.28].

The investigators found for the comparison of the highest with lowest categories of plant protein intakes a non-significant reduced risk of 5% for type 2 diabetes [RR = 0.95, 95% CI = 0.89 to 1.02]. Non-significant means it cannot be said with a 95% confidence that a daily higher intake of plant protein really reduced risk of type 2 diabetes with 5%.

The investigators found for the comparison of the highest with lowest categories of plant protein intakes a significant reduced risk of 7% for type 2 diabetes among women [RR = 0.93, 95% CI = 0.85 to 1.00].

The investigators found for the comparison of the highest with lowest categories of plant protein intakes a significant reduced risk of 9% for type 2 diabetes among US populations [RR = 0.91, 95% CI = 0.84 to 0.97].

The investigators concluded that a higher intake of total and animal protein are both associated with an increased risk of of type 2 diabetes. However, a higher intake of plant protein decreases risk of type 2 diabetes among women and US populations.

Original title:
Dietary protein intake and risk of type 2 diabetes: results from the Melbourne Collaborative Cohort Study and a meta-analysis of prospective studies by Shang X, Scott D, […], Sanders KM.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/27629053

Additional information of El Mondo:
Find more information/studies on diabetes and protein right here.

Objectives:
Micronutrient deficiencies impose a considerable burden of disease on many middle and low income countries. Several strategies have been shown to be effective in improving micronutrient deficiencies. However, the impact of fortified condiments as well as fortified noodles is less well documented. Therefore, this meta-analysis (review article) has been conducted.

What is the impact of micronutrient fortified condiments on hemoglobin, anemia and functional outcomes in children and adults (age: 5 to 50 years)?

Study design:
This review article included 14 RCTs comprising 8845 people with a mean age between 7.3 and 34 years. Mean follow-up was 0.88 years (range: 2.4 months to 2 years).

Only in 2 trials was multi-micronutrient fortification used, e.g. additional fortification with vitamin A, zinc and folate. In the other 12 studies, iron was the net difference in multi-micronutrient exposition between intervention and control groups.

Results and conclusions:
The investigators found in 12 RCTs that micronutrient fortification of condiments significantly increased hemoglobin concentrations by 0.74 g/dL [95% CI = 0.56 to 0.93].

The investigators found different types of iron preparations showed no differences in rise of hemoglobin concentrations (NaFeEDTA: 0.69 g/dL vs. 0.68 g/dL for other preparations).

The investigators found micronutrient fortification also led to a reduced risk of 41% for having anemia [risk ratio 0.59, 95% CI = 0.44 to 0.80].

The investigators found ferritin concentrations significantly increased with fortified condiments.

The investigators concluded the use of micronutrient fortified condiments can be a strategy to reduce anemia in children and adults due to micronutrient deficiencies beyond supplementation programs and fortification of staple food.

Original title:
Micronutrient Fortified Condiments and Noodles to Reduce Anemia in Children and Adults—A Literature Review and Meta-Analysis by Hess S, Tecklenburg L and Eichler K.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772051/

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and iron right here.
 

Objectives:
The aim of this review article was to assess the relation between the level of habitual potassium intake and the incidence of cardiovascular disease (CVD).

Study design:
This review article included 15 cohort studies involving a total of 247510 male and female participants, 7,066 strokes, 3,058 coronary heart disease (CHD) events and 2,497 total CVD events.
The weighted average follow-up time was 12.2 years (range 5 to 19 years).
There was significant heterogeneity among studies in terms of sample size, duration of observation, number of events and difference in dietary potassium intake between the groups being compared. This heterogeneity led to a reduced statistical power in detecting a possible association between dietary potassium and coronary heart disease and cardiovascular disease.

There was no evidence of publication bias by the Egger test.

Potassium intake was assessed by 24-h dietary recall (n = 2), food frequency questionnaire (n = 6) or 24-h urinary excretion (n = 3).

Results and conclusions:
The investigators found in a pooled analysis, a dietary intake of 1.64g (42 mmol) potassium per day was significantly associated with a 21% lower risk of stroke [RR = 0.79, 95% CI = 0.68 to 0.90, p = 0.0007]. Significant means it can be said with a 95% confidence that a daily intake of 1.64g potassium really decreased the risk of having a stroke.

The investigators found a trend toward an inverse association between higher potassium intake (average weighted difference = 1.38g or 35.3 mmol/day) and risk of coronary heart disease [RR = 0.92, 95% CI = 0.81 to 1.04], which was not statistically significant [p = 0.18].
Not significant means it cannot be said with a 95% confidence that a daily intake of 1.38g potassium really decreased the risk of coronary heart disease with 8%. 

The investigators found a trend toward an inverse relationship between higher potassium intake (average weighted difference = 1.30g or 33.4 mmol/day) and cardiovascular disease risk [RR = 0.85, 95% CI = 0.62 to 1.16], which was not statistically significant [p = 0.31].

The investigators found a trend toward lower risk of CHD [RR = 0.93, 95% CI = 0.87 to 0.99, p = 0.03] and total CVD [RR = 0.74, 95% CI = 0.60 to 0.91, p = 0.0037] that attained statistical significance after the exclusion of a single cohort, based on sensitivity analysis.

The results of meta-regression analyses indicated that potassium intake difference, length of follow-up, quality score, recruitment year and population potassium intake at baseline were not significant sources of heterogeneity in the relationship of the potassium intake effect on the risk of CHD.

The results of meta-regression analyses indicated that the length of follow-up (coefficient: -0.064, 95% CI = -0.112 to -0.015, p = 0.01) and quality score (coefficient: -0.165, 95% CI = -0.287 to -0.043, p = 0.01) were significant sources of heterogeneity.

The investigators concluded that 1.64g dietary potassium per day decreases the risk of having a stroke and might also reduce the risk of coronary heart disease and total cardiovascular disease. This result applies to the general population, not only to specific subgroups at higher risk.
The favorable effects of dietary potassium were documented at least to some extent independently of other factors.
The results of this meta-analysis support recommendations for higher consumption of potassium-rich foods to prevent vascular diseases.

Original title:
Potassium Intake, Stroke, and Cardiovascular Disease : A Meta-Analysis of Prospective Studies by D'Elia L, Barba G, [...], Strazzullo P.

Link:
http://www.sciencedirect.com/science/article/pii/S0735109710049764

Additional information of El Mondo:
Find more information/studies on potassium right here.
The protective effect of potassium against the risk of stroke may conceivably relate to its blood pressure lowering effect.

Objectives:
Does garlic supplementation reduce cardiovascular disease risk?

Study design:
This review article included original studies and previous review articles (meta-analyses).

Results and conclusions:
The investigators found in 4 meta-analyses and 2 original studies that garlic supplementation significantly reduced blood pressure by 7-16 mmHg (systolic) and 5-9 mmHg (diastolic). Significant means that there is an association with a 95% confidence.

The investigators found in 8 meta-analyses that garlic supplementation significantly reduced total cholesterol by 7.4-29.8 mg/dL.

The most consistent benefits were shown in studies that used aged garlic extract (AGE).

The investigators found a few small studies that used aged garlic extract also showed favourable effects on C-reactive protein (CRP), pulse wave velocity (PWV), and coronary artery calcium (CAC).

Although garlic is generally safe, rare adverse reactions have been documented with limited causality established.

The investigators concluded garlic supplementation has the potential for cardiovascular protection based on risk factor reduction (hypertension and total cholesterol) and surrogate markers (C-reactive protein, pulse wave velocity and coronary artery calcium) of atherosclerosis. Larger studies are warranted to evaluate these effects further.

Original title:
Garlic and Heart Disease by Varshney R and Budoff MJ.

Link:
http://jn.nutrition.org/content/146/2/416S.long

Additional information of El Mondo:
Find more information/studies on garlic consumption and cardiovascular disease right here.

Objectives:
There is no published systematic review and meta-analysis regarding the effect of olive oil consumption on cancer occurrence. Therefore, this review article has been conducted.

Does olive oil consumption reduce cancer risk?

Study design:
This review article included 19 case-control studies (13800 cancer patients and 23340 controls).

Random effects meta-analysis was applied in order to evaluate the research hypothesis.
Heterogeneity of the effect-size measures was observed in studies performed in the Mediterranean region (n = 15, p = 0.0002), whereas no heterogeneity was observed in non-Mediterranean studies (n = 4, p = 0.12).

Results and conclusions:
The investigators found when comparing with the lowest, the highest category of olive oil consumption was significantly associated with lower odds of having any type of cancer [log odds ratio = -0.41, 95% CI = -0.53 to -0.29, Cohran's Q = 47.52, p = 0.0002, I2 = 62%].

The investigators found both Mediterranean and non-Mediterranean people reported olive oil intake were less likely to have developed any type of cancer.

The investigators found olive oil consumption was significantly associated with lower odds of developing breast cancer [logOR = -0.4,  95% CI = -0.78 to -0.12] and a cancer of the digestive system [logOR = -0.36, 95% CI = -0.50 to -0.21] compared with the lowest intake.

The investigators concluded olive oil consumption probably reduces risk of any type of cancer, especially breast cancer and cancer of the digestive system. Probably, because this review article only included case-control studies and there was heterogeneity.
The reduced risk is similar to studies performed in Mediterranean as well as non-Mediterranean countries. However, it is still unclear whether olive oil's monounsaturated fatty acid content or its antioxidant components are responsible for its beneficial effects.

Original title:
Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13800 patients and 23340 controls in 19 observational studies by Psaltopoulou T, Kosti RI, […], Panagiotakos DB.

Link:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199852/

Additional information of El Mondo:
Find more studies on olive oil consumption and fat.

Objectives:
Zinc deficiency is a global nutritional problem, particularly in children and women residing in settings where diets are cereal based and monotonous. It has several negative health consequences. Fortification of staple foods with zinc may be an effective strategy for preventing zinc deficiency and improving zinc-related health outcomes. Therefore, this meta-analysis (review article) has been conducted.

What are the beneficial and adverse effects of fortification of staple foods with zinc on health-related outcomes and biomarkers of zinc status in the general population?

Study design:
This review article included 8 RCTs (709 participants); seven were from middle-income countries of Asia, Africa, Europe and Latin America where zinc deficiency is likely to be a public health problem.
The interventions lasted between one and nine months.

Results and conclusions:
The investigators found in 3 studies with 158 participants that foods fortified with zinc increased the serum or plasma zinc levels with 2.12 µmol/L in comparison to foods without added zinc [MD = 2.12 µmol/L, 95% CI = 1.25 to 3.00 µmol/L; low-quality evidence].

The investigators found in 2 studies with 397 participants that participants consuming foods fortified with zinc versus participants consuming the same food without zinc had similar risk of underweight [average risk ratio = 3.10, 95% CI = 0.52 to 18.38; low-quality evidence].

The investigators found in 2 studies with 397 participants that participants consuming foods fortified with zinc versus participants consuming the same food without zinc had similar risk of stunting [RR = 0.88, 95% CI = 0.36 to 2.13; low-quality evidence].

The investigators found no significant difference in serum or plasma zinc levels in participants consuming foods fortified with zinc plus other micronutrients comparing with participants consuming the same foods with micronutrients but no added zinc [MD = 0.03 µmol/L, 95% CI = -0.67 to 0.72 µmol/L; 4 studies of  low-quality evidence with 250 participants].

The investigators found no adverse effect of fortification of foods with zinc on indicators of iron or copper status.

The investigators concluded fortification of foods with zinc may improve the serum zinc status of populations if zinc is the only micronutrient used for fortification. However, when zinc is added to food in combination with other micronutrients, it may make little or no difference to the serum zinc status. Effects of fortification of foods with zinc on other outcomes including zinc deficiency, children's growth, cognition, work capacity of adults or on haematological indicators are unknown. Given the small number of trials and participants in each trial, further investigation of these outcomes is required.

Original title:
Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population by Shah D, Sachdev HS, […], Peña-Rosas JP.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/27281654

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and zinc right here.
 

Objectives:
Anemia is a leading cause of maternal deaths and adverse pregnancy outcomes in developing countries. To present knowledge, no previous study has estimated the population-attributable fraction (PAF) of adverse pregnancy outcomes for maternal anemia. Therefore, this meta-analysis (review article) has been conducted.

Is there an association between maternal anemia and pregnancy outcomes in low- and middle-income countries?

Study design:
This review article included 24 prospective cohorts and 5 retrospective cohort studies.

The number of subjects per study ranged from 253 to 399,274 with a total of ∼0.72 million pregnant women with a mean age that ranged from 20 to 30 years.

Results and conclusions:
The investigators found overall, 42.7% [95% CI = 37.0% to 48.4%] of women experienced anemia during pregnancy in low- and middle-income countries.

The investigators found pregnant women with anemia had a significant higher risk of 31% for low birth weight [RR = 1.31, 95% CI = 1.13-1.51].

The investigators found pregnant women with anemia had a significant higher risk of 63% for preterm birth [RR = 1.63, 95% CI = 1.33-2.01].

The investigators found pregnant women with anemia had a significant higher risk of 51% for perinatal mortality [RR = 1.51, 95% CI = 1.30-1.76].

The investigators found pregnant women with anemia had a significant higher risk of 172% for neonatal mortality [RR = 2.72, 95% CI = 1.19-6.25].

The investigators found South Asian, African and low-income countries had a higher pooled anemia prevalence than did other Asian and upper-middle-income countries.

The investigators found in low- and middle-income countries, 12% of low birth weight, 19% of preterm births and 18% of perinatal mortality were attributable to maternal anemia.

The investigators concluded maternal anemia is a risk factor for adverse birth and perinatal health outcomes in low- and middle-income countries. Significantly higher risk of low birth weight and preterm birth were observed in low-income countries and in South Asian countries despite the greater priority and larger investment on maternal and child health programs in recent decades.

Original title:
Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis by Rahman MM, Abe SK, […], Shibuya K.

Link:
http://ajcn.nutrition.org/content/103/2/495.long

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and iron right here.